actbiotechАктуальная биотехнологияTopical biotechnology2304-4691ВГУИТ10.20914/2304-4691-2019-3-385-388actbiotech-4290Research ArticleСтатьиСВЕРХРАННИЕ БЕЛКИ ЦИТОМЕГАЛОВИРУСА УЧАСТВУЮТ В УСТАНОВЛЕНИИ РЕЗИСТЕНТНОСТИ К ПРОТИВООПУХОЛЕВОМУ АНТИБИОТИКУ ДОКСОРУБИЦИНУ ИНФИЦИРОВАННЫХ КЛЕТОК ЛЕЙКЕМИИ ТНР-1ЧернорыжЯ. Ю.noemail@neicon.ruЮрловК. И.noemail@neicon.ruСимоновР. А.noemail@neicon.ruФедороваН. Е.noemail@neicon.ruКущА. А.noemail@neicon.ruНИЦЭМ им. Н.Ф. Гамалеи Минздрава РоссииRussian Federation20191809201903385388Copyright © Чернорыж Я.Ю., Юрлов К.И., Симонов Р.А., Федорова Н.Е., Кущ А.А., 20192019Чернорыж Я.Ю., Юрлов К.И., Симонов Р.А., Федорова Н.Е., Кущ А.А.Чернорыж Я.Ю., Юрлов К.И., Симонов Р.А., Федорова Н.Е., Кущ А.А.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.actbio-vsuet.ru/jour/article/view/4290ReferencesSöderberg-Nauclér C., Johnsen J.I. Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options // World J Exp Med. 2015; 5(1): 1-10Söderberg-Nauclér C., Johnsen J.I. Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options // World J Exp Med. 2015; 5(1): 1-10Tsuchiya S., Yamabe M., Yamaguchi Y., et al. Establishment and characterization of a human acute monocytic leukemia cell line (THP 1) // Int. J. Cancer 1980; 26: 171-176Tsuchiya S., Yamabe M., Yamaguchi Y., et al. Establishment and characterization of a human acute monocytic leukemia cell line (THP 1) // Int. J. Cancer 1980; 26: 171-176Yang F., Teves S.S., Kemp C.J., Henikoff S. Doxorubicin, DNA torsion, and chromatin dynamics // Biochim Biophys Acta 2014; 1845: 84-89Yang F., Teves S.S., Kemp C.J., Henikoff S. Doxorubicin, DNA torsion, and chromatin dynamics // Biochim Biophys Acta 2014; 1845: 84-89Tolosa L, Donato MT, Gómez-Lechón MJ. General Cytotoxicity Assessment by Means of the MTT Assay // Methods Mol Biol. 2015; 1250: 333-48.Tolosa L, Donato MT, Gómez-Lechón MJ. General Cytotoxicity Assessment by Means of the MTT Assay // Methods Mol Biol. 2015; 1250: 333-48.Cheng S., Caviness K., Buehler J., et al. Transcriptome-wide characterization of human cytomegalovirus in natural infection and experimental latency // Proc Natl Acad Sci USA. 2017; 114(49): p. Е10586 Е10595.Cheng S., Caviness K., Buehler J., et al. Transcriptome-wide characterization of human cytomegalovirus in natural infection and experimental latency // Proc Natl Acad Sci USA. 2017; 114(49): p. Е10586 Е10595.Arcangeletti M., Vasile S., Rodighiero I, et al. Human cytomegalovirus reactivation from latency: validation of a "switch" model in vitro // Virol J. 2016; 13(1): 179.Arcangeletti M., Vasile S., Rodighiero I, et al. Human cytomegalovirus reactivation from latency: validation of a "switch" model in vitro // Virol J. 2016; 13(1): 179.Mocarski E., Shenk T., Griffiths P.D., Pass F.R. Cytomegaloviruses. Knipe D.M., Howley P.M., editors. Fields Virology. 6th ed. Volume 2. USA: Lippincott Williams and Wilkins, Philadelphia; 2013.Mocarski E., Shenk T., Griffiths P.D., Pass F.R. Cytomegaloviruses. Knipe D.M., Howley P.M., editors. Fields Virology. 6th ed. Volume 2. USA: Lippincott Williams and Wilkins, Philadelphia; 2013.Spector D.H. Human cytomegalovirus riding the cell cycle // Med Microbiol Immunol. 2015; 204(3): 409-419.Spector D.H. Human cytomegalovirus riding the cell cycle // Med Microbiol Immunol. 2015; 204(3): 409-419.
The authors declare that there are no conflicts of interest present.